Not Yet RecruitingPhase 4

Dual Trigger With HCG and GnRH Agonist on Thawed Modified Natural Cycle Embryo Transfer

170 participantsStarted 2026-01-01

Plain-language summary

Impact of dual trigger using recombinant human chorionic gonadotropin (HCG) and gonadotropin-releasing hormone (GnRH) agonist on thawed modified natural cycle outcomes: an open-label multi-center randomized controlled trial.

Who can participate

Age range25 Years – 44 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: 1\. 24\<= Age \< 45 patient undergo mNC-FET Exclusion Criteria: 1\. Congenital or acquired uterine abnormalities (uterine malformation, submucosal myoma, intrauterine adhesion or endometrial polyp \>1cm)

What they're measuring

Implantation

Timeframe: 14 days after embryo transfer

Trial details

NCT IDNCT07269392

SponsorNational Taiwan University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-12-31

Contact for this trial

william lee

+886972652396 wylee@ntuh.gov.tw

View on ClinicalTrials.gov More In Vitro Fertilization (IVF) trials